Henry Ford Health System

Thank You for Participating in the STRIVE Study

Your participation in the STRIVE Study is bringing Henry Ford Health System, GRAIL, and its collaborators one step closer to developing an important new tool to detect cancer early. Thank you for completing the first phase of your STRIVE Study participation. Your continued engagement in the follow-up phase will help with the ongoing development of the GRAIL blood test.

  • Inform Study Coordinators of Contact Information Changes
  • Inform Study Coordinators of Any New Cancer Diagnosis
  • Complete the Study Follow-Up
  • Provide Additional Blood Sample(s) if Indicated
  • Screening Mammogram
  • Read and Sign the Informed Consent Form
  • Complete the Study Questionnaire
  • Provide a Blood Sample

The success of the STRIVE Study depends on our ability to follow participants for cancer events over time. This follow-up is critical to the development of a blood test for the early detection of cancer. The STRIVE Study team will be reaching out to participants occasionally to collect study follow-up information. Additionally, study researchers will also be actively monitoring electronic health records for up to 5 years from enrollment to capture clinical outcome data, including cancer diagnoses.

Keeping your contact information up to date is very important so that the study team at your health center can reach you during the follow-up period. Please contact the study team by emailing STRIVE@hfhs.org or by calling 1-833-3-STRIVE (1-833-378-7483) if:

  • Your contact information changes
  • You receive a cancer diagnosis, or
  • You receive cancer care outside of the Henry Ford health system


Have questions about the study? Visit our frequently asked questions page.

Sample Consent Form

Review a sample consent form that fully explains what participation involves.

Start typing and press Enter to search